Radiopharmaceuticals
Total Trials
3
As Lead Sponsor
2
As Collaborator
1
Total Enrollment
235
NCT01562301
Sublingual Anvirzel in Advance Non-Small Cell Lung Cancer (NSCLC)
Phase: Phase 1
Role: Collaborator
Start: Jun 30, 2014
Completion: Not specified
NCT05422105
Diagnostic Performance of 18F-PSMA-1007 PET/CT in Suspected Prostate Cancer Patient
Phase: N/A
Role: Lead Sponsor
Start: Jul 1, 2023
Completion: Dec 31, 2024
NCT06935149
Detecting Colorectal Cancer With Liver Metastatic Lesions Using Novel Precise Imaging Tools
Start: May 1, 2025
Completion: Dec 31, 2025
Loading map...